Search research articles
Contact Us
Filters
Showing results (81-90 of 82) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 82 results.
The Lancet. Oncology
|
July 27, 2019
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 2020
Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 82) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 82 results.
The Lancet. Oncology
|
July 27, 2019
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 2020
Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
Cathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.
Page
of 9